OncoScint CR/OV monoclonal-based imaging agent targeting the TAG-72 glycoprotein expressed by colon and breast cancer cell lines: Began multicenter Phase II tri

Cytogen Corp. (CYTO), Princeton,

Read the full 43 word article

How to gain access

Continue reading with a
two-week free trial.